enVVeno Medical (NVNO) EBITDA Margin (2017 - 2019)
enVVeno Medical's (NVNO) quarterly EBITDA Margin came in at 5064.63% in Q1 2019, down 37628.0% year-on-year from N/an in Q1 2018, and up 14.24% quarter-over-quarter from 5905.47% in Q4 2018.
enVVeno Medical (NVNO) EBITDA Margin (2017 - 2019) Analysis & Trends
enVVeno Medical's EBITDA Margin history runs 3 years deep, the most recent figure standing at 5064.63% for Q1 2019.
- On a quarterly basis, EBITDA Margin fell 37628.0% year-over-year to 5064.63% in Q1 2019; TTM through Dec 2019 was 24566.51%, a 2035600.0% decrease from a year earlier, with the FY2019 full-year figure at 24566.5%, down 2035599.0% from the prior year.
- EBITDA Margin advanced to 5064.63% in Q1 2019 per NVNO's latest filing, from 5905.47% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1101.34% in Q4 2017 and bottomed at 6499.91% in Q3 2017.
- The 3-year median for EBITDA Margin is 4210.58% (2018), against an average of 4217.23%.
- Biggest YoY gain for EBITDA Margin was 292915 bps in 2018; the steepest drop was 480413 bps in 2018.
- Year by year, EBITDA Margin stood at 1101.34% in 2017, then plunged by 436 bps to 5905.47% in 2018, then advanced by 14 bps to 5064.63% in 2019.
- Per Business Quant, the three latest NVNO EBITDA Margin figures stand at 5064.63% (Q1 2019), 5905.47% (Q4 2018), and 3570.75% (Q3 2018).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -5,064.63% |
| Dec 31, 2018 | -5,905.47% |
| Sep 30, 2018 | -3,570.75% |
| Jun 30, 2018 | -3,732.81% |
| Mar 31, 2018 | -4,688.35% |
| Dec 31, 2017 | -1,101.34% |
| Sep 30, 2017 | -6,499.91% |
| Jun 30, 2017 | -3,174.60% |